Dr Phil Jones and Dr Lori Passmore join a total of 80 exceptional scientists from around the world elected as Fellows and Foreign Members of the Royal Society this year.
These individuals have pushed forward the boundaries of their respective fields and had a beneficial influence on the world beyond.
Dr Phil Jones is a Senior Group Leader, Wellcome Sanger Institute and Professor of Cancer Development, University of Cambridge.
He has found that different mutations can either promote or inhibit cancer development giving hope of new ways to prevent cancer in the future. He is also a Consultant in Medical Oncology at Addenbrooke’s Hospital in Cambridge.
He said: “I am delighted to be elected to the Fellowship of the Royal Society. This honour is a tribute to the dedication of my research team and collaborators and support of my mentors and scientific colleagues over many years.”
Dr Lori Passmore is a Group Leader, MRC Laboratory of Molecular Biology, and member of our Cell and Molecular Biology Programme.
Dr Passmore is a cryo-electron microscopist and structural biologist known for her work on multiprotein complexes involved in gene expression and the development of new supports for cryo-EM studies.
She also studies the molecular mechanisms underlying Fanconi anemia, a rare genetic disease resulting in an impaired response to DNA damage.
The Society’s fundamental purpose is to recognise, promote, and support excellence in science and to encourage the development and use of science for the benefit of humanity.
Sir Adrian Smith, President of the Royal Society said: “I am delighted to welcome our newest cohort of Fellows. These individuals have pushed forward the boundaries of their respective fields and had a beneficial influence on the world beyond.
"This year’s intake have already achieved incredible things, and I have no doubt that they will continue to do so. I look forward to meeting them and following their contributions in future.”